201 related articles for article (PubMed ID: 20008988)
1. Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands.
Terry GE; Hirvonen J; Liow JS; Zoghbi SS; Gladding R; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Donohue SR; Pike VW; Halldin C; Innis RB
J Nucl Med; 2010 Jan; 51(1):112-20. PubMed ID: 20008988
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand.
Terry GE; Liow JS; Zoghbi SS; Hirvonen J; Farris AG; Lerner A; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Hong JS; Pike VW; Halldin C; Innis RB
Neuroimage; 2009 Nov; 48(2):362-70. PubMed ID: 19573609
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography.
Terry GE; Hirvonen J; Liow JS; Seneca N; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Pike VW; Halldin C; Innis RB
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1499-506. PubMed ID: 20333514
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors.
Tsujikawa T; Zoghbi SS; Hong J; Donohue SR; Jenko KJ; Gladding RL; Halldin C; Pike VW; Innis RB; Fujita M
Neuroimage; 2014 Jan; 84():733-41. PubMed ID: 24076222
[TBL] [Abstract][Full Text] [Related]
5. Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.
Riaño Barros DA; McGinnity CJ; Rosso L; Heckemann RA; Howes OD; Brooks DJ; Duncan JS; Turkheimer FE; Koepp MJ; Hammers A
Neuroimage; 2014 Aug; 97():151-62. PubMed ID: 24736184
[TBL] [Abstract][Full Text] [Related]
6. The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.
Yasuno F; Brown AK; Zoghbi SS; Krushinski JH; Chernet E; Tauscher J; Schaus JM; Phebus LA; Chesterfield AK; Felder CC; Gladding RL; Hong J; Halldin C; Pike VW; Innis RB
Neuropsychopharmacology; 2008 Jan; 33(2):259-69. PubMed ID: 17392732
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents.
Terry G; Liow JS; Chernet E; Zoghbi SS; Phebus L; Felder CC; Tauscher J; Schaus JM; Pike VW; Halldin C; Innis RB
Neuroimage; 2008 Jul; 41(3):690-8. PubMed ID: 18456516
[TBL] [Abstract][Full Text] [Related]
8. Population-based input function modeling for [(18)F]FMPEP-d 2, an inverse agonist radioligand for cannabinoid CB1 receptors: validation in clinical studies.
Zanotti-Fregonara P; Hirvonen J; Lyoo CH; Zoghbi SS; Rallis-Frutos D; Huestis MA; Morse C; Pike VW; Innis RB
PLoS One; 2013; 8(4):e60231. PubMed ID: 23577094
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEP.
Suter TM; Chesterfield AK; Bao C; Schaus JM; Krushinski JH; Statnick MA; Felder CC
Eur J Pharmacol; 2010 Dec; 649(1-3):44-50. PubMed ID: 20851117
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.
Finnema SJ; Donohue SR; Zoghbi SS; Brown AK; Gulyás B; Innis RB; Halldin C; Pike VW
Synapse; 2009 Jan; 63(1):22-30. PubMed ID: 18925657
[TBL] [Abstract][Full Text] [Related]
11. Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A.
Lohith TG; Zoghbi SS; Morse CL; Araneta MF; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
J Nucl Med; 2012 Mar; 53(3):385-92. PubMed ID: 22312136
[TBL] [Abstract][Full Text] [Related]
12. Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors.
Imaizumi M; Briard E; Zoghbi SS; Gourley JP; Hong J; Fujimura Y; Pike VW; Innis RB; Fujita M
Neuroimage; 2008 Feb; 39(3):1289-98. PubMed ID: 18024084
[TBL] [Abstract][Full Text] [Related]
13. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging.
Donohue SR; Krushinski JH; Pike VW; Chernet E; Phebus L; Chesterfield AK; Felder CC; Halldin C; Schaus JM
J Med Chem; 2008 Sep; 51(18):5833-42. PubMed ID: 18800770
[TBL] [Abstract][Full Text] [Related]
15. The Cannabinoid Receptor-1 Is an Imaging Biomarker of Brown Adipose Tissue.
Eriksson O; Mikkola K; Espes D; Tuominen L; Virtanen K; Forsbäck S; Haaparanta-Solin M; Hietala J; Solin O; Nuutila P
J Nucl Med; 2015 Dec; 56(12):1937-41. PubMed ID: 26359260
[TBL] [Abstract][Full Text] [Related]
16. Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors.
Kimura Y; Fujita M; Hong J; Lohith TG; Gladding RL; Zoghbi SS; Tauscher JA; Goebl N; Rash KS; Chen Z; Pedregal C; Barth VN; Pike VW; Innis RB
J Nucl Med; 2011 Oct; 52(10):1638-45. PubMed ID: 21880575
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization in monkey of [11C]SP203 as a radioligand for imaging brain metabotropic glutamate 5 receptors.
Siméon FG; Liow JS; Zhang Y; Hong J; Gladding RL; Zoghbi SS; Innis RB; Pike VW
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1949-58. PubMed ID: 22885775
[TBL] [Abstract][Full Text] [Related]
18. PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119.
Hamill TG; Lin LS; Hagmann W; Liu P; Jewell J; Sanabria S; Eng W; Ryan C; Fong TM; Connolly B; Vanko A; Hargreaves R; Goulet MT; Burns HD
Mol Imaging Biol; 2009; 11(4):246-52. PubMed ID: 19130142
[TBL] [Abstract][Full Text] [Related]
19. Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia.
Jenko KJ; Hirvonen J; Henter ID; Anderson KB; Zoghbi SS; Hyde TM; Deep-Soboslay A; Innis RB; Kleinman JE
Schizophr Res; 2012 Nov; 141(2-3):185-8. PubMed ID: 22910406
[TBL] [Abstract][Full Text] [Related]
20. Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects.
Van Laere K; Koole M; Sanabria Bohorquez SM; Goffin K; Guenther I; Belanger MJ; Cote J; Rothenberg P; De Lepeleire I; Grachev ID; Hargreaves RJ; Bormans G; Burns HD
J Nucl Med; 2008 Mar; 49(3):439-45. PubMed ID: 18287275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
